[English] 日本語

- EMDB-70021: BG505-DS SOSIP in complex with 007 bNAb Fabs - Class 3 (3 Fabs bound) -
+
Open data
-
Basic information
Entry | ![]() | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | BG505-DS SOSIP in complex with 007 bNAb Fabs - Class 3 (3 Fabs bound) | |||||||||
![]() | Sharpened EM map | |||||||||
![]() |
| |||||||||
![]() | antibody / envelope / SOSIP / VIRAL PROTEIN-IMMUNE SYSTEM complex | |||||||||
Function / homology | ![]() positive regulation of plasma membrane raft polarization / positive regulation of receptor clustering / host cell endosome membrane / clathrin-dependent endocytosis of virus by host cell / viral protein processing / fusion of virus membrane with host plasma membrane / fusion of virus membrane with host endosome membrane / viral envelope / virion attachment to host cell / host cell plasma membrane ...positive regulation of plasma membrane raft polarization / positive regulation of receptor clustering / host cell endosome membrane / clathrin-dependent endocytosis of virus by host cell / viral protein processing / fusion of virus membrane with host plasma membrane / fusion of virus membrane with host endosome membrane / viral envelope / virion attachment to host cell / host cell plasma membrane / virion membrane / structural molecule activity / identical protein binding / membrane Similarity search - Function | |||||||||
Biological species | ![]() ![]() ![]() | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 3.4 Å | |||||||||
![]() | DeLaitsch AT / Bjorkman PJ | |||||||||
Funding support | ![]()
| |||||||||
![]() | ![]() Title: Identification of a broad and potent V3 glycan site bNAb targeting an N332 glycan-independent epitope. Authors: Lutz Gieselmann / Andrew T DeLaitsch / Malena Rohde / Caelan Radford / Johanna Worczinski / Anna Momot / Elvin Ahmadov / Judith A Burger / Colin Havenar-Daughton / Sharvari Deshpande / ...Authors: Lutz Gieselmann / Andrew T DeLaitsch / Malena Rohde / Caelan Radford / Johanna Worczinski / Anna Momot / Elvin Ahmadov / Judith A Burger / Colin Havenar-Daughton / Sharvari Deshpande / Federico Giovannoni / Davide Corti / Christoph Kreer / Meryem Seda Ercanoglu / Philipp Schommers / Ivelin S Georgiev / Anthony P West / Jacqueline Knüfer / Ricarda Stumpf / Arne Kroidl / Christof Geldmacher / Lucas Maganga / Wiston William / Nyanda E Ntinginya / Michael Hoelscher / Zhengrong Yang / Qing Wei / Matthew Renfrow / Todd J Green / Jan Novak / Marit J van Gils / Harry B Gristick / Henning Gruell / Jesse D Bloom / Michael S Seaman / Pamela J Bjorkman / Florian Klein / ![]() ![]() ![]() Abstract: Broadly neutralizing antibodies (bNAbs) against HIV-1 can suppress viremia and inform vaccine development. Here, we characterized 007, a V3 glycan site bNAb exhibiting high levels of antiviral ...Broadly neutralizing antibodies (bNAbs) against HIV-1 can suppress viremia and inform vaccine development. Here, we characterized 007, a V3 glycan site bNAb exhibiting high levels of antiviral activity against multiclade pseudovirus panels (GeoMean IC = 0.012 μg/mL, breadth = 69%, 217 virus strains) by targeting a N332 glycan-independent V3 epitope, a site of Env vulnerability to which only weakly neutralizing antibodies had previously been identified. Functional analyses demonstrated distinct binding and neutralization profiles compared to classical V3 glycan site bNAbs. A 007 Fab-Env cryo-EM structure revealed contacts with the V3 GD/NIR motif and interactions with N156 and N301 glycans. In contrast to classical V3 bNAbs, 007 binding to Env does not depend on the N332 glycan, rendering it resistant to common escape mutations. Structures of 007 IgG-Env trimer complexes showed two Env trimers crosslinked by three bivalent IgGs, and bivalent 007 IgG was up to ~300-fold more potent than monovalent 007 IgG heterodimer, suggesting a role for avidity in potent neutralization. Finally, in HIV-1-infected humanized mice, 007 caused transient decline of viremia and overcame classical V3 escape mutations, highlighting 007's potential for HIV-1 prevention, therapy, functional cure, and vaccine design. | |||||||||
History |
|
-
Structure visualization
Supplemental images |
---|
-
Downloads & links
-EMDB archive
Map data | ![]() | 217 MB | ![]() | |
---|---|---|---|---|
Header (meta data) | ![]() ![]() | 25.8 KB 25.8 KB | Display Display | ![]() |
FSC (resolution estimation) | ![]() | 13 KB | Display | ![]() |
Images | ![]() | 107.7 KB | ||
Filedesc metadata | ![]() | 7.6 KB | ||
Others | ![]() ![]() ![]() | 114.6 MB 213.5 MB 213.5 MB | ||
Archive directory | ![]() ![]() | HTTPS FTP |
-Validation report
Summary document | ![]() | 1.1 MB | Display | ![]() |
---|---|---|---|---|
Full document | ![]() | 1.1 MB | Display | |
Data in XML | ![]() | 22 KB | Display | |
Data in CIF | ![]() | 28.4 KB | Display | |
Arichive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
Related structure data | ![]() 9o2tMC ![]() 9o2qC ![]() 9o2rC ![]() 9o2sC ![]() 9o2uC M: atomic model generated by this map C: citing same article ( |
---|---|
Similar structure data | Similarity search - Function & homology ![]() |
-
Links
EMDB pages | ![]() ![]() |
---|---|
Related items in Molecule of the Month |
-
Map
File | ![]() | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Sharpened EM map | ||||||||||||||||||||||||||||||||||||
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 0.832 Å | ||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
-Additional map: Unsharpened EM map
File | emd_70021_additional_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Unsharpened EM map | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: EM half map A
File | emd_70021_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | EM half map A | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: EM half map B
File | emd_70021_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | EM half map B | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-
Sample components
-Entire : HIV-1 BG505-DS SOSIP trimer bound by three 007 bNAb Fabs
Entire | Name: HIV-1 BG505-DS SOSIP trimer bound by three 007 bNAb Fabs |
---|---|
Components |
|
-Supramolecule #1: HIV-1 BG505-DS SOSIP trimer bound by three 007 bNAb Fabs
Supramolecule | Name: HIV-1 BG505-DS SOSIP trimer bound by three 007 bNAb Fabs type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1-#4 |
---|---|
Source (natural) | Organism: ![]() |
-Macromolecule #1: Envelope glycoprotein gp120
Macromolecule | Name: Envelope glycoprotein gp120 / type: protein_or_peptide / ID: 1 / Number of copies: 3 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: ![]() ![]() |
Molecular weight | Theoretical: 53.414547 KDa |
Recombinant expression | Organism: ![]() |
Sequence | String: NLWVTVYYGV PVWKDAETTL FCASDAKAYE TEKHNVWATH ACVPTDPNPQ EIHLENVTEE FNMWKNNMVE QMHTDIISLW DQSLKPCVK LTPLCVTLQC TNVTNNITDD MRGELKNCSF NMTTELRDKK QKVYSLFYRL DVVQINENQG NRSNNSNKEY R LINCNTSA ...String: NLWVTVYYGV PVWKDAETTL FCASDAKAYE TEKHNVWATH ACVPTDPNPQ EIHLENVTEE FNMWKNNMVE QMHTDIISLW DQSLKPCVK LTPLCVTLQC TNVTNNITDD MRGELKNCSF NMTTELRDKK QKVYSLFYRL DVVQINENQG NRSNNSNKEY R LINCNTSA CTQACPKVSF EPIPIHYCAP AGFAILKCKD KKFNGTGPCP SVSTVQCTHG IKPVVSTQLL LNGSLAEEEV MI RSENITN NAKNILVQFN TPVQINCTRP NNNTRKSIRI GPGQAFYATG DIIGDIRQAH CNVSKATWNE TLGKVVKQLR KHF GNNTII RFANSSGGDL EVTTHSFNCG GEFFYCNTSG LFNSTWISNT SVQGSNSTGS NDSITLPCRI KQIINMWQRI GQCM YAPPI QGVIRCVSNI TGLILTRDGG STNSTTETFR PGGGDMRDNW RSELYKYKVV KIEPLGVAPT RCKRRVVGRR R UniProtKB: Envelope glycoprotein gp160 |
-Macromolecule #2: Envelope glycoprotein gp41
Macromolecule | Name: Envelope glycoprotein gp41 / type: protein_or_peptide / ID: 2 / Number of copies: 3 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: ![]() ![]() |
Molecular weight | Theoretical: 17.618064 KDa |
Recombinant expression | Organism: ![]() |
Sequence | String: RRRAVGIGAV FLGFLGAAGS TMGAASMTLT VQARNLLSGI VQQQSNLLRA PEAQQHLLKL TVWGIKQLQA RVLAVERYLR DQQLLGIWG CSGKLICCTN VPWNSSWSNR NLSEIWDNMT WLQWDKEISN YTQIIYGLLE ESQNQQEKNE QDLLALD UniProtKB: Envelope glycoprotein gp160 |
-Macromolecule #3: 007 Fab Heavy Chain
Macromolecule | Name: 007 Fab Heavy Chain / type: protein_or_peptide / ID: 3 / Number of copies: 3 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 26.07643 KDa |
Recombinant expression | Organism: ![]() |
Sequence | String: QARLQQWEGR PLKPAETLSL TCGVHGVGLG GSGWGWIRQP PGQGLQWIGE IDHDGSHKHN PALRSRLSMS LDTSRNQVSL RLTSVTAAD TAIYYCVRVY REKFLIGEFL TDYRFMDMWG TGTTVIVSPA STKGPSVFPL APSSKSTSGG TAALGCLVKD Y FPEPVTVS ...String: QARLQQWEGR PLKPAETLSL TCGVHGVGLG GSGWGWIRQP PGQGLQWIGE IDHDGSHKHN PALRSRLSMS LDTSRNQVSL RLTSVTAAD TAIYYCVRVY REKFLIGEFL TDYRFMDMWG TGTTVIVSPA STKGPSVFPL APSSKSTSGG TAALGCLVKD Y FPEPVTVS WNSGALTSGV HTFPAVLQSS GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKRVEP KSCDKTHHHH HH |
-Macromolecule #4: 007 Light Chain
Macromolecule | Name: 007 Light Chain / type: protein_or_peptide / ID: 4 / Number of copies: 3 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 23.50027 KDa |
Recombinant expression | Organism: ![]() |
Sequence | String: AIQLTQAPLT VSASIGDTIT LTCRASQDIS IWLSWYRQMP GKAPELLIYA ASTLRGGVPS RFSGARSGTD FSLKIKNLQP EDFATYYCF QSDSYPRAFG QGTKVEITRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS Q ESVTEQDS ...String: AIQLTQAPLT VSASIGDTIT LTCRASQDIS IWLSWYRQMP GKAPELLIYA ASTLRGGVPS RFSGARSGTD FSLKIKNLQP EDFATYYCF QSDSYPRAFG QGTKVEITRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS Q ESVTEQDS KDSTYSLSST LTLSKADYEK HKVYACEVTH QGLSSPVTKS FNRGEC |
-Macromolecule #8: 2-acetamido-2-deoxy-beta-D-glucopyranose
Macromolecule | Name: 2-acetamido-2-deoxy-beta-D-glucopyranose / type: ligand / ID: 8 / Number of copies: 24 / Formula: NAG |
---|---|
Molecular weight | Theoretical: 221.208 Da |
Chemical component information | ![]() ChemComp-NAG: |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
![]() | single particle reconstruction |
Aggregation state | particle |
-
Sample preparation
Concentration | 3.4 mg/mL | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Buffer | pH: 8 Component:
| |||||||||
Grid | Model: Quantifoil R1.2/1.3 / Material: COPPER / Mesh: 300 / Support film - Material: CARBON / Pretreatment - Type: GLOW DISCHARGE | |||||||||
Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 295 K / Instrument: FEI VITROBOT MARK IV / Details: 3s blot, 0 blot force. |
-
Electron microscopy
Microscope | TFS KRIOS |
---|---|
Image recording | Film or detector model: GATAN K3 (6k x 4k) / Number grids imaged: 1 / Number real images: 6695 / Average electron dose: 60.0 e/Å2 |
Electron beam | Acceleration voltage: 300 kV / Electron source: ![]() |
Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 3.0 µm / Nominal defocus min: 1.0 µm / Nominal magnification: 105000 |
Sample stage | Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER / Cooling holder cryogen: NITROGEN |
Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
+
Image processing
-Atomic model buiding 1
Initial model |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
Refinement | Space: REAL / Protocol: RIGID BODY FIT | ||||||||
Output model | ![]() PDB-9o2t: |